APA (7th ed.) Citation

JA, N., M, L., MA, T., A, A., C, G., R, R., . . . JA, K. (2026). Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): A multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. The Lancet. Respiratory medicine, 14(5), 443. https://doi.org/10.1016/S2213-2600(26)00047-0

Chicago Style (17th ed.) Citation

JA, Neyra, et al. "Polymyxin B Haemoadsorption in Endotoxic Septic Shock (Tigris): A Multicentre, Open-label, Bayesian, Randomised, Controlled, Phase 3 Trial." The Lancet. Respiratory Medicine 14, no. 5 (2026): 443. https://doi.org/10.1016/S2213-2600(26)00047-0.

MLA (9th ed.) Citation

JA, Neyra, et al. "Polymyxin B Haemoadsorption in Endotoxic Septic Shock (Tigris): A Multicentre, Open-label, Bayesian, Randomised, Controlled, Phase 3 Trial." The Lancet. Respiratory Medicine, vol. 14, no. 5, 2026, p. 443, https://doi.org/10.1016/S2213-2600(26)00047-0.